Balance Sheet West Pharmaceutical Services, Inc.

Equities

WST

US9553061055

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 02:30:03 11/02/2026 am IST			5-day change	1st Jan Change
243.56 ^USD	-2.16%		+5.46%	-11.48%

10/02	Jefferies Adjusts Price Target on West Pharmaceutical Services to $295 From $365, Maintains Buy Rating	MT
05/02	West Pharmaceutical Services, Inc. - Special Call

41dec2.RZ_Tt9G4mp_XrZhp1qMTI4NuYgG88bbZcThpTJwIEQ4.L--x0rfh_PCQxfsRj9tbG9s8CU_Phd2DJ20hJ8h5fmQXqaDB5szvqKT67w

Published financial data: WEST PHARMACEUTICAL SERVICES, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	214.69Cr	283.16Cr	288.69Cr	294.98Cr	289.32Cr
Total Revenues	214.69Cr	283.16Cr	288.69Cr	294.98Cr	289.32Cr
Cost of Goods Sold, Total	137.91Cr	165.58Cr	175.07Cr	181.98Cr	189.47Cr
Gross Profit	77Cr	117.58Cr	113.62Cr	113Cr	100Cr
Selling General & Admin Expenses, Total	30Cr	36Cr	32Cr	35Cr	33Cr
Stock-Based Compensation (IS)	-	-	-	-	-
R&D Expenses	4.69Cr	5.28Cr	5.85Cr	6.84Cr	6.91Cr
Other Operating Expenses	-	-	-21L	13L	9L
Other Operating Expenses, Total	35Cr	41Cr	37Cr	42Cr	40Cr
Operating Income	42Cr	76Cr	76Cr	71Cr	59Cr
Interest Expense, Total	-82L	-82L	-79L	-90L	-30L
Interest And Investment Income	14L	10L	51L	2.8Cr	1.96Cr
Net Interest Expenses	-68L	-72L	-28L	1.9Cr	1.66Cr
Income (Loss) On Equity Invest.	1.74Cr	2.01Cr	2.07Cr	1.77Cr	1.47Cr
Currency Exchange Gains (Loss)	15L	14L	41L	-94L	-1.02Cr
EBT, Excl. Unusual Items	43Cr	78Cr	79Cr	73Cr	61Cr
Restructuring Charges	-46L	-22L	-2.38Cr	20L	-21L
Gain (Loss) On Sale Of Investments	-	-43L	-35L	-43L	-3L
Gain (Loss) On Sale Of Assets	-	-	-	-1.16Cr	-
Asset Writedown	-77L	-13L	-27L	-53L	-70L
Legal Settlements	-	-	-	38L	-
Other Unusual Items	-12L	-15L	-5.52Cr	-24L	-51L
EBT, Incl. Unusual Items	42Cr	77Cr	70Cr	72Cr	60Cr
Income Tax Expense	7.25Cr	11Cr	11Cr	12Cr	11Cr
Earnings From Continuing Operations	35Cr	66Cr	59Cr	59Cr	49Cr
Net Income to Company	35Cr	66Cr	59Cr	59Cr	49Cr
Net Income - (IS)	35Cr	66Cr	59Cr	59Cr	49Cr
Net Income to Common Incl Extra Items	35Cr	66Cr	59Cr	59Cr	49Cr
Net Income to Common Excl. Extra Items	35Cr	66Cr	59Cr	59Cr	49Cr
Per Share Items
Net EPS - Basic	4.68	8.9	7.88	7.99	6.75
Basic EPS - Continuing Operations	4.68	8.9	7.88	7.99	6.75
Basic Weighted Average Shares Outstanding	7.39Cr	7.44Cr	7.44Cr	7.43Cr	7.3Cr
Net EPS - Diluted	4.57	8.67	7.73	7.88	6.69
Diluted EPS - Continuing Operations	4.57	8.67	7.73	7.88	6.69
Diluted Weighted Average Shares Outstanding	7.58Cr	7.63Cr	7.58Cr	7.53Cr	7.37Cr
Normalized Basic EPS	3.66	6.54	6.6	6.17	5.26
Normalized Diluted EPS	3.56	6.38	6.48	6.09	5.21
Dividend Per Share	0.65	0.69	0.73	0.77	0.81
Payout Ratio	13.89	7.72	9.23	9.61	12
Supplemental Items
EBITDA	53Cr	89Cr	88Cr	84Cr	75Cr
EBITA	42Cr	77Cr	77Cr	71Cr	60Cr
EBIT	42Cr	76Cr	76Cr	71Cr	59Cr
EBITDAR	55Cr	91Cr	91Cr	88Cr	78Cr
Effective Tax Rate - (Ratio)	17.32	13.94	16.37	17.09	17.91
Current Domestic Taxes	3.23Cr	7.57Cr	8.41Cr	2.6Cr	3.19Cr
Current Foreign Taxes	4.6Cr	7.44Cr	6.14Cr	5.88Cr	7.91Cr
Total Current Taxes	7.83Cr	15Cr	15Cr	8.48Cr	11Cr
Deferred Domestic Taxes	2L	73L	-2.03Cr	-1.16Cr	-1.83Cr
Deferred Foreign Taxes	-60L	-5.02Cr	-1.05Cr	4.91Cr	1.48Cr
Total Deferred Taxes	-58L	-4.29Cr	-3.08Cr	3.75Cr	-35L
Normalized Net Income	27Cr	49Cr	49Cr	46Cr	38Cr
Interest Capitalized	14L	20L	37L	58L	1.32Cr
Interest on Long-Term Debt	96L	1.02Cr	1.16Cr	1.48Cr	1.62Cr
Non-Cash Pension Expense	12L	-20L	5.26Cr	22L	24L
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	4.69Cr	5.28Cr	5.85Cr	6.84Cr	6.91Cr
Net Rental Expense, Total	1.74Cr	1.88Cr	2.36Cr	3.19Cr	3.57Cr
Imputed Operating Lease Interest Expense	40.37L	46.73L	68.1L	1.2Cr	1.51Cr
Imputed Operating Lease Depreciation	1.34Cr	1.41Cr	1.68Cr	1.99Cr	2.06Cr
Stock-Based Comp., SG&A Exp. (Total)	3.4Cr	3.75Cr	2.37Cr	2.33Cr	1.87Cr
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	3.4Cr	3.75Cr	2.37Cr	2.33Cr	1.87Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	62Cr	76Cr	89Cr	85Cr	48Cr
Total Cash And Short Term Investments	62Cr	76Cr	89Cr	85Cr	48Cr
Accounts Receivable, Total	39Cr	49Cr	52Cr	53Cr	58Cr
Total Receivables	39Cr	49Cr	52Cr	53Cr	58Cr
Inventory	32Cr	38Cr	41Cr	43Cr	38Cr
Other Current Assets, Total	5.16Cr	11Cr	8.67Cr	11Cr	10Cr
Total Current Assets	137.37Cr	174.2Cr	191.95Cr	193.64Cr	153.81Cr
Gross Property Plant And Equipment	210.38Cr	228.43Cr	249.1Cr	283.72Cr	312Cr
Accumulated Depreciation	-109.23Cr	-115.75Cr	-122.83Cr	-132.47Cr	-140.42Cr
Net Property Plant And Equipment	101.15Cr	112.68Cr	126.27Cr	151.25Cr	171.58Cr
Long-term Investments	21Cr	21Cr	20Cr	21Cr	20Cr
Goodwill	11Cr	11Cr	11Cr	11Cr	11Cr
Other Intangibles, Total	3.05Cr	2.3Cr	1.84Cr	1.51Cr	1.08Cr
Accounts Receivable Long-Term	1.09Cr	1.46Cr	-	-	-
Deferred Tax Assets Long-Term	1.6Cr	4.85Cr	6.56Cr	2.57Cr	2.6Cr
Deferred Charges Long-Term	4L	1L	-	-	-
Other Long-Term Assets, Total	2.5Cr	4.12Cr	3.84Cr	2.13Cr	4.46Cr
Total Assets	279.38Cr	331.38Cr	361.68Cr	382.95Cr	364.34Cr
Liabilities
Accounts Payable, Total	21Cr	23Cr	22Cr	24Cr	24Cr
Accrued Expenses, Total	15Cr	19Cr	14Cr	16Cr	14Cr
Current Portion of Long-Term Debt	23L	4.42Cr	22L	13Cr	-
Current Portion of Leases	1.01Cr	93L	1.6Cr	1.77Cr	1.88Cr
Current Income Taxes Payable	2.6Cr	2.63Cr	2.48Cr	2.18Cr	3.15Cr
Unearned Revenue Current, Total	5.1Cr	4.87Cr	5.73Cr	4.17Cr	4.96Cr
Other Current Liabilities	5.18Cr	4.73Cr	6.01Cr	5.81Cr	7.32Cr
Total Current Liabilities	50Cr	59Cr	52Cr	67Cr	55Cr
Long-Term Debt	26Cr	21Cr	21Cr	7.28Cr	20Cr
Long-Term Leases	6.04Cr	6.3Cr	9.3Cr	8.45Cr	8.39Cr
Unearned Revenue Non Current	38L	30L	21L	1.22Cr	36L
Pension & Other Post Retirement Benefits	5.75Cr	4.05Cr	2.82Cr	2.96Cr	2.82Cr
Deferred Tax Liability Non Current	1.04Cr	49L	1.43Cr	1.27Cr	2.05Cr
Other Non Current Liabilities	4.53Cr	6.41Cr	6.86Cr	6.49Cr	7.19Cr
Total Liabilities	94Cr	98Cr	93Cr	95Cr	96Cr
Common Stock, Total	1.88Cr	1.88Cr	1.88Cr	1.88Cr	1.88Cr
Additional Paid In Capital	27Cr	25Cr	23Cr	12Cr	2.21Cr
Retained Earnings	184.67Cr	245.67Cr	298.78Cr	352.34Cr	395.66Cr
Treasury Stock	-17Cr	-23Cr	-37Cr	-64Cr	-105.71Cr
Comprehensive Income and Other	-11Cr	-16Cr	-18Cr	-14Cr	-26Cr
Total Common Equity	185.45Cr	233.54Cr	268.49Cr	288.1Cr	268.23Cr
Total Equity	185.45Cr	233.54Cr	268.49Cr	288.1Cr	268.23Cr
Total Liabilities And Equity	279.38Cr	331.38Cr	361.68Cr	382.95Cr	364.34Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	7.41Cr	7.43Cr	7.41Cr	7.33Cr	7.23Cr
ECS Total Common Shares Outstanding	7.4Cr	7.42Cr	7.41Cr	7.35Cr	7.23Cr
Book Value / Share	25.05	31.47	36.23	39.2	37.1
Tangible Book Value	171.29Cr	220.25Cr	255.92Cr	275.74Cr	256.55Cr
Tangible Book Value Per Share	23.14	29.68	34.54	37.52	35.48
Total Debt	33Cr	33Cr	32Cr	31Cr	31Cr
Net Debt	-28Cr	-44Cr	-58Cr	-54Cr	-18Cr
Debt Equivalent of Unfunded Proj. Benefit Obligation	4.08Cr	2.06Cr	2.61Cr	2.52Cr	2.4Cr
Debt Equivalent Oper. Leases	14Cr	15Cr	19Cr	26Cr	29Cr
Equity Method Investments, Total	21Cr	21Cr	20Cr	21Cr	20Cr
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	13Cr	15Cr	17Cr	17Cr	17Cr
Inventories - Work In Process, Total	5.49Cr	6.35Cr	7.9Cr	8.73Cr	6.52Cr
Inventories - Finished Goods, Total	13Cr	16Cr	17Cr	18Cr	14Cr
Land - (BS)	2.48Cr	2.93Cr	2.9Cr	3.37Cr	2.79Cr
Buildings, Total	62Cr	64Cr	66Cr	77Cr	92Cr
Machinery, Total	120.05Cr	129.82Cr	138.81Cr	151.76Cr	163.1Cr
Full Time Employees	9.2T	10.06T	10.7T	10.6T	10.6T
Part Time Employees	-	-	-	-	-
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	11L	4L	2L	8L	8L
Order Backlog	-	-	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	35Cr	66Cr	59Cr	59Cr	49Cr
Depreciation & Amortization - CF	10Cr	12Cr	12Cr	13Cr	15Cr
Amortization of Goodwill and Intangible Assets - (CF)	44L	54L	37L	36L	36L
Depreciation & Amortization, Total	11Cr	12Cr	12Cr	14Cr	16Cr
(Gain) Loss From Sale Of Asset	-	-	-	1.16Cr	-
Asset Writedown & Restructuring Costs	77L	13L	1.8Cr	96L	73L
(Income) Loss On Equity Investments - (CF)	-1.58Cr	-1.74Cr	-1.81Cr	-1.43Cr	-1.34Cr
Stock-Based Compensation (CF)	3.4Cr	3.75Cr	2.37Cr	2.33Cr	1.87Cr
Other Operating Activities, Total	16L	-2.77Cr	54L	3.6Cr	-1.02Cr
Change In Accounts Receivable	-4.66Cr	-12Cr	-3.56Cr	40L	-5.88Cr
Change In Inventories	-7.37Cr	-8.65Cr	-4.98Cr	-1.35Cr	4.2Cr
Change In Accounts Payable	3.66Cr	1.68Cr	-28L	44L	29L
Change in Other Net Operating Assets	7.34Cr	-6L	7.67Cr	-1.53Cr	1.68Cr
Cash from Operations	47Cr	58Cr	72Cr	78Cr	65Cr
Capital Expenditure	-17Cr	-25Cr	-28Cr	-36Cr	-38Cr
Cash Acquisitions	-	-22L	-	-	-
Divestitures	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-	-	-	-	-
Other Investing Activities, Total	-51L	25L	-36L	-67L	-17L
Cash from Investing	-18Cr	-25Cr	-29Cr	-37Cr	-38Cr
Long-Term Debt Issued, Total	-	-	-	-	16Cr
Total Debt Issued	-	-	-	-	16Cr
Long-Term Debt Repaid, Total	-23L	-22L	-4.43Cr	-23L	-19Cr
Total Debt Repaid	-23L	-22L	-4.43Cr	-23L	-19Cr
Issuance of Common Stock	2.88Cr	3.71Cr	2.82Cr	5.1Cr	3.27Cr
Repurchase of Common Stock	-12Cr	-15Cr	-22Cr	-45Cr	-57Cr
Common Dividends Paid	-4.81Cr	-5.11Cr	-5.41Cr	-5.7Cr	-5.91Cr
Common & Preferred Stock Dividends Paid	-4.81Cr	-5.11Cr	-5.41Cr	-5.7Cr	-5.91Cr
Other Financing Activities, Total	-	-	-12L	-1L	-20L
Cash from Financing	-14Cr	-17Cr	-29Cr	-46Cr	-62Cr
Foreign Exchange Rate Adjustments	2.05Cr	-1.57Cr	-1.05Cr	1.14Cr	-2.14Cr
Net Change in Cash	18Cr	15Cr	13Cr	-4.04Cr	-37Cr
Supplemental Items
Cash Interest Paid	81L	80L	66L	60L	5L
Cash Income Tax Paid (Refund)	4.84Cr	17Cr	11Cr	9.08Cr	7.14Cr
Levered Free Cash Flow	25Cr	21Cr	25Cr	20Cr	21Cr
Unlevered Free Cash Flow	25Cr	21Cr	25Cr	20Cr	21Cr
Change In Net Working Capital	-2.27Cr	17Cr	8.56Cr	3.8Cr	-4.05Cr
Net Debt Issued / Repaid	-23L	-22L	-4.43Cr	-23L	-2.76Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	10.23	15.64	13.78	11.85	9.93
Return on Total Capital	12.84	19.7	16.86	14.25	12.01
Return On Equity %	20.2	31.59	23.34	21.32	17.71
Return on Common Equity	20.2	31.59	23.34	21.32	17.71
Margin Analysis
Gross Profit Margin %	35.76	41.52	39.36	38.31	34.51
SG&A Margin	14.01	12.68	10.95	12	11.58
EBITDA Margin %	24.65	31.3	30.63	28.6	25.89
EBITA Margin %	19.77	27.17	26.59	24.06	20.64
EBIT Margin %	19.57	26.98	26.46	23.94	20.52
Income From Continuing Operations Margin %	16.13	23.37	20.3	20.12	17.03
Net Income Margin %	16.13	23.37	20.3	20.12	17.03
Net Avail. For Common Margin %	16.13	23.37	20.3	20.12	17.03
Normalized Net Income Margin	12.58	17.18	17.01	15.54	13.28
Levered Free Cash Flow Margin	11.59	7.32	8.54	6.66	7.15
Unlevered Free Cash Flow Margin	11.83	7.5	8.71	6.85	7.21
Asset Turnover
Asset Turnover	0.84	0.93	0.83	0.79	0.77
Fixed Assets Turnover	2.24	2.65	2.42	2.13	1.79
Receivables Turnover (Average Receivables)	6.09	6.48	5.62	5.58	5.22
Inventory Turnover (Average Inventory)	4.95	4.73	4.41	4.28	4.67
Short Term Liquidity
Current Ratio	2.73	2.93	3.7	2.88	2.79
Quick Ratio	1.99	2.11	2.73	2.07	1.93
Operating Cash Flow to Current Liabilities	0.94	0.98	1.39	1.16	1.19
Days Sales Outstanding (Average Receivables)	60.06	56.35	64.94	65.41	70.17
Days Outstanding Inventory (Average Inventory)	73.91	77.12	82.69	85.19	78.4
Average Days Payable Outstanding	46.22	47.44	45.71	45.41	47.99
Cash Conversion Cycle (Average Days)	87.76	86.03	101.92	105.19	100.58
Long Term Solvency
Total Debt/Equity	17.86	13.93	11.84	10.73	11.38
Total Debt / Total Capital	15.16	12.23	10.59	9.69	10.22
LT Debt/Equity	17.2	11.64	11.16	5.46	10.68
Long-Term Debt / Total Capital	14.59	10.22	9.98	4.93	9.59
Total Liabilities / Total Assets	33.62	29.52	25.77	24.77	26.38
EBIT / Interest Expense	51.23	93.17	96.68	78.47	197.87
EBITDA / Interest Expense	66.66	110.38	114.94	97.27	261.57
(EBITDA - Capex) / Interest Expense	45.39	79.48	78.91	57.04	135.9
Total Debt / EBITDA	0.61	0.36	0.35	0.35	0.39
Net Debt / EBITDA	-0.52	-0.48	-0.63	-0.62	-0.23
Total Debt / (EBITDA - Capex)	0.89	0.5	0.51	0.6	0.75
Net Debt / (EBITDA - Capex)	-0.76	-0.67	-0.92	-1.06	-0.44
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	16.69	31.89	1.95	2.18	-1.92
Gross Profit, 1 Yr. Growth %	26.76	53.14	-3.52	-0.55	-11.64
EBITDA, 1 Yr. Growth %	32.5	67.48	-0.53	-4.62	-11.2
EBITA, 1 Yr. Growth %	41.78	81.25	-0.61	-7.52	-15.86
EBIT, 1 Yr. Growth %	41.93	81.86	-0.39	-7.54	-15.94
Earnings From Cont. Operations, 1 Yr. Growth %	43.24	91.16	-11.47	1.28	-16.97
Net Income, 1 Yr. Growth %	43.24	91.16	-11.47	1.28	-16.97
Normalized Net Income, 1 Yr. Growth %	41.8	80.08	0.6	-6.66	-16.2
Diluted EPS Before Extra, 1 Yr. Growth %	42.37	89.72	-10.84	1.94	-15.1
Accounts Receivable, 1 Yr. Growth %	20.67	26.91	3.99	1.87	7.93
Inventory, 1 Yr. Growth %	36.32	17.77	9.62	4.8	-13.27
Net Property, Plant and Equip., 1 Yr. Growth %	11.23	11.4	12.06	19.78	13.44
Total Assets, 1 Yr. Growth %	19.32	18.61	9.14	5.88	-4.86
Tangible Book Value, 1 Yr. Growth %	19.32	28.58	16.2	7.74	-6.96
Common Equity, 1 Yr. Growth %	17.88	25.93	14.97	7.3	-6.9
Cash From Operations, 1 Yr. Growth %	28.68	23.6	23.97	7.25	-15.85
Capital Expenditures, 1 Yr. Growth %	37.97	45.3	12.31	27.2	4.14
Levered Free Cash Flow, 1 Yr. Growth %	51.19	-16.74	18	-20.36	5.28
Unlevered Free Cash Flow, 1 Yr. Growth %	49.48	-16.4	17.48	-19.68	3.28
Dividend Per Share, 1 Yr. Growth %	6.56	6.15	5.8	5.48	5.19
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	11.81	24.06	15.96	2.07	0.11
Gross Profit, 2 Yr. CAGR %	18.65	39.33	21.65	-2.05	-6.26
EBITDA, 2 Yr. CAGR %	22.04	48.97	28.97	-2.7	-7.97
EBITA, 2 Yr. CAGR %	29.38	60.31	34.07	-4.24	-11.79
EBIT, 2 Yr. CAGR %	29.4	60.66	34.44	-4.15	-11.84
Earnings From Cont. Operations, 2 Yr. CAGR %	29.36	65.47	30.09	-5.31	-8.3
Net Income, 2 Yr. CAGR %	29.36	65.47	30.09	-5.31	-8.3
Normalized Net Income, 2 Yr. CAGR %	29.5	59.8	34.45	-3.21	-11.55
Diluted EPS Before Extra, 2 Yr. CAGR %	29.15	64.35	30.06	-4.66	-6.97
Accounts Receivable, 2 Yr. CAGR %	15.63	23.75	16.58	2.93	4.86
Inventory, 2 Yr. CAGR %	22.39	26.71	13.62	7.18	-4.67
Net Property, Plant and Equip., 2 Yr. CAGR %	10.93	11.31	11.73	15.86	16.57
Total Assets, 2 Yr. CAGR %	18.82	18.97	13.78	7.5	0.37
Tangible Book Value, 2 Yr. CAGR %	16.13	23.86	22.23	11.89	0.12
Common Equity, 2 Yr. CAGR %	15.25	21.84	20.32	11.07	-0.05
Cash From Operations, 2 Yr. CAGR %	27.95	26.11	23.79	15.31	-5
Capital Expenditures, 2 Yr. CAGR %	29.06	41.59	27.75	19.52	15.09
Levered Free Cash Flow, 2 Yr. CAGR %	43.37	12.19	-0.77	-3.32	-8.43
Unlevered Free Cash Flow, 2 Yr. CAGR %	41.8	11.78	-0.8	-3.12	-8.92
Dividend Per Share, 2 Yr. CAGR %	6.79	6.36	5.98	5.64	5.34
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	10.32	18.14	16.2	11.17	0.72
Gross Profit, 3 Yr. CAGR %	14.39	29.18	23.33	13.75	-5.35
EBITDA, 3 Yr. CAGR %	16.36	35.62	30.34	16.63	-5.62
EBITA, 3 Yr. CAGR %	20.67	44.77	36.86	18.46	-8.28
EBIT, 3 Yr. CAGR %	20.65	44.94	37.16	18.67	-8.25
Earnings From Cont. Operations, 3 Yr. CAGR %	31.95	47.34	34.33	19.68	-9.37
Net Income, 3 Yr. CAGR %	31.95	47.34	34.33	19.68	-9.37
Normalized Net Income, 3 Yr. CAGR %	21.34	44.55	37.12	19.05	-7.75
Diluted EPS Before Extra, 3 Yr. CAGR %	31.93	46.81	34.04	19.91	-8.28
Accounts Receivable, 3 Yr. CAGR %	15.02	19.27	17.93	11.46	4.57
Inventory, 3 Yr. CAGR %	14.29	20.83	20.73	10.6	-0.12
Net Property, Plant and Equip., 3 Yr. CAGR %	5.76	11.09	11.56	14.35	15.05
Total Assets, 3 Yr. CAGR %	14.47	18.75	15.6	11.08	3.21
Tangible Book Value, 3 Yr. CAGR %	14.19	20.14	21.25	17.2	5.22
Common Equity, 3 Yr. CAGR %	13.16	18.7	19.5	15.82	4.72
Cash From Operations, 3 Yr. CAGR %	21.52	26.48	25.39	18.01	3.81
Capital Expenditures, 3 Yr. CAGR %	10.06	34.26	31.07	27.56	14.16
Levered Free Cash Flow, 3 Yr. CAGR %	36.05	19.61	14.42	-7.79	-0.53
Unlevered Free Cash Flow, 3 Yr. CAGR %	34.79	18.9	13.96	-7.54	-1.03
Dividend Per Share, 3 Yr. CAGR %	7.04	6.58	6.17	5.81	5.49
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	8.93	13.41	12.54	11.43	9.48
Gross Profit, 5 Yr. CAGR %	10.99	18.58	17.24	15.68	10.51
EBITDA, 5 Yr. CAGR %	19.19	22.63	21.36	18.88	13.4
EBITA, 5 Yr. CAGR %	25.96	27.15	26.01	22.86	14.81
EBIT, 5 Yr. CAGR %	26.42	27.26	26.14	22.99	14.93
Earnings From Cont. Operations, 5 Yr. CAGR %	29.35	35.74	31.2	23.46	15.31
Net Income, 5 Yr. CAGR %	29.35	35.74	31.2	23.46	15.31
Normalized Net Income, 5 Yr. CAGR %	28.49	27.6	26.57	23.27	15.06
Diluted EPS Before Extra, 5 Yr. CAGR %	28.59	35.33	31.18	23.53	15.82
Accounts Receivable, 5 Yr. CAGR %	16.26	19.52	15.64	13.11	12.52
Inventory, 5 Yr. CAGR %	12.15	13.68	14.02	15.17	9.85
Net Property, Plant and Equip., 5 Yr. CAGR %	7.01	7.68	8.11	12.97	13.54
Total Assets, 5 Yr. CAGR %	10.51	14.06	14.19	14.12	9.25
Tangible Book Value, 5 Yr. CAGR %	14.2	17.31	17.34	16.77	12.31
Common Equity, 5 Yr. CAGR %	12.61	15.88	15.97	15.59	11.26
Cash From Operations, 5 Yr. CAGR %	17.34	21.63	22.42	21.89	12.22
Capital Expenditures, 5 Yr. CAGR %	5.79	8.29	16.82	28.16	24.43
Levered Free Cash Flow, 5 Yr. CAGR %	24.02	45.29	20.06	10.16	4.66
Unlevered Free Cash Flow, 5 Yr. CAGR %	22.09	41.78	19.38	9.84	4.19
Dividend Per Share, 5 Yr. CAGR %	7.63	7.09	6.61	6.2	5.84